Mittie Doyle

Business address
C/O Dice Therapeutics, Inc., 279 E. Grand Avenue, Suite 300, Lobby B, South San Francisco, CA, 94080
Top holdings (ownership)
AVTX
⭐ Add to watchlist ⭐
Get insider transactions for this reporting owner
Mittie Doyle has filed 9 SEC EDGAR filings since 01 Apr 2022

Latest Filings

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open Document Open Filing STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES 12 Dec 2025 10 Dec 2025 001-37590
4 Open Document Open Filing 4 08 Aug 2025 07 Aug 2025 001-39856
3 Open Document Open Filing 3 08 Aug 2025 07 Aug 2025 001-39856
4 Open Document Open Filing PRIMARY DOCUMENT 30 Jan 2025 28 Jan 2025 001-37590
4 Open Document Open Filing PRIMARY DOCUMENT 16 Jul 2024 15 Jul 2024 001-37590
3 Open Document Open Filing PRIMARY DOCUMENT 16 Jul 2024 15 Jul 2024 001-37590
4 Open Document Open Filing FORM 4 SUBMISSION 09 Aug 2023 09 Aug 2023 001-40794
4 Open Document Open Filing FORM 4 SUBMISSION 01 Apr 2022 31 Mar 2022 001-40794
3 Open Document Open Filing FORM 3 SUBMISSION 01 Apr 2022 24 Mar 2022 001-40794